Published in Eur J Biochem on January 02, 1985
Structure and expression of elongation factor 1 alpha in tomato. Nucleic Acids Res (1989) 2.28
Developmental analysis of elongation factor-1 alpha expression in transgenic tobacco. Plant Cell (1991) 1.37
The tumour promoter okadaic acid inhibits reticulocyte-lysate protein synthesis by increasing the net phosphorylation of elongation factor 2. Biochem J (1989) 1.10
Expression of three genes for elongation factor 1 alpha during morphogenesis of Mucor racemosus. Mol Cell Biol (1987) 1.07
[Recommendations for diagnosis and therapy of chronic heart failure 2001--the short version]. Vnitr Lek (2004) 1.95
Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT). Cardiovasc Res (2001) 1.53
The role of cholesteryl 14-methylhexadecanoate in peptide elongation reactions. Biochem J (1971) 1.23
Influence of cholesteryl 14-methylhexadecanoate on some ribosomal functions required for peptide elongation. Biochem J (1974) 1.12
Effect of cholesteryl 14-methylhexadecanoate on the activity of some amino acid-transfer ribonucleic acid ligases from mammalian tissues. Biochem J (1969) 1.06
The chemical constitution of carcinolipin. Biochem J (1968) 0.97
All factors required for protein synthesis are retained on heparin bound to Sepharose. Biochem J (1978) 0.94
Effect of some polycyclic aromatic hydrocarbons on protein synthesis in vitro. Biochem J (1967) 0.93
Intermediate reactions in the binding of aminoacyl-transfer ribonucleic acid to rat liver ribosomes. Formation and properties of an aminoacyl-transfer ribonucleic acid-transferase I complex. Biochem J (1972) 0.92
Decreased activity of peptide-elongation factors after treatment with cholesterol esterase. Biochem J (1978) 0.92
Effect of lipids, in particular cholesteryl 14-methylhexadecanoate, on the incorporation of labelled amino acids into transfer ribonucleic acid in vitro. Biochem J (1968) 0.91
Intermediate reactions in the binding of aminoacyl-transfer ribonucleic acid to rat liver ribosomes. the interaction of cholesteryl 14-methylhexadecanoate. Biochem J (1972) 0.90
Isolation of carcinolipin by combined liquid-solid and liquid-liquid chromatography. J Chromatogr (1968) 0.88
A chromatographic method for the quantitative determination of cholesterol 14-methylhexadecanoate (carcinolipin) in biological materials. J Chromatogr (1968) 0.87
Intermediate reactions in the binding of aminoacyl-transfer ribonucleic acid to rat liver ribosomes. The role of guanosine triphosphate. Biochem J (1972) 0.87
Purification of the fatty acid present in carcinolipin. J Chromatogr (1968) 0.86
Effect of cholesteryl 14-methylhexadecanoate on the RNA polymerase activity of rat liver nuclei in vivo and in vitro. FEBS Lett (1971) 0.86
Heart in adrenal diseases. Cor Vasa (1992) 0.85
Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure. Physiol Res (2008) 0.83
The role of cholesteryl 14-methylhexadecanoate in gene expression and its significance for cancer. Prog Biochem Pharmacol (1975) 0.81
Purification and some properties of a protein factor binding and deacylating initiator transfer ribonucleic acid. Biochem J (1979) 0.80
Protein synthesis in the liver of rats injected with cholesteryl 14-methylhexadecanoate. Biochem J (1972) 0.80
Specific hydrolysis of methionyl-tRNA Met f catalyzed by a purified peptide. Nucleic Acids Res (1975) 0.79
Ribosome-dependent conversion of polyA-containing heterogenous nuclear RNA into smaller RNA molecules. Nucleic Acids Res (1975) 0.79
Valvular regurgitations in healthy young people. Cor Vasa (1989) 0.79
Valsartan and atenolol in patients with severe essential hypertension. J Hum Hypertens (1998) 0.79
Natriuretic and kaliuretic effect of melanocyte-stimulating hormones in hamsters. Endocrinol Exp (1979) 0.79
[Recommendations for the treatment of tobacco dependence]. Cas Lek Cesk (2005) 0.78
Purification and some properties of peptide initiation factors from rat liver. Acta Biol Med Ger (1974) 0.78
Detoxication products of the carcinogenic azodye Sudan I (solvent yellow 14) bind to nucleic acids after activation by peroxidase. Cancer Lett (1993) 0.77
Mechanism of formation and 32P-postlabeling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I). Carcinogenesis (1990) 0.77
Expression and interaction of different catenins in colorectal carcinoma cells. Int J Mol Med (2001) 0.77
The role of cholesteryl 14-methylhexadecanoate in the function of eukaryotic peptide elongation factor 1. Eur J Biochem (1985) 0.77
Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press (2006) 0.77
Changes of aminoacyl-tRNA synthesis in the liver of rats administered cholesteryl 14-methylhexadecanoate. FEBS Lett (1971) 0.77
Purification and some properties of a cholesterol esterase from rat liver. Biochim Biophys Acta (1980) 0.77
Peroxidase-mediated reaction of the carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene with transfer ribonucleic acid. Carcinogenesis (1990) 0.77
Heart in thyroid diseases. Cor Vasa (1992) 0.76
Repolarization pattern of body surface potential maps (BSPM) in coronary artery disease. Physiol Res (1993) 0.76
Particulate aminoacyl-tRNA synthetases are retained on heparin bound to Sepharose. Mol Biol Rep (1980) 0.76
Effect of short-term maximal exercise on BNP plasma levels in healthy individuals. Physiol Res (2009) 0.76
Changes of E-cadherin and beta-catenin levels during induced differentiation of colorectal carcinoma cells. Int J Mol Med (1999) 0.76
Different binding of poly(A)-containing and poly(A)-free fractions of nuclear ribonucleic acid to ribosomes from rat liver. Biochim Biophys Acta (1975) 0.76
Comparison of M-mode echocardiography and angiography in the evaluation of left ventricular hypertrophy. Cor Vasa (1986) 0.76
Heparin-sepharose 4B at low temperatures retains ribosomes. Biochem J (1978) 0.75
Cholesteryl esters are bound by a peptide-initiation and a peptide-elongation factor. Biochem J (1980) 0.75
[Long-term study of glucose tolerance in individuals with a suspected diagnosis of diabetes]. Vnitr Lek (1993) 0.75
[Disorders of the cardiovascular system in Turner's syndrome]. Cas Lek Cesk (1990) 0.75
Activity of cholesterol-esterifying enzymes from rat liver cytosol is affected by malignant growth. Oncol Rep (1996) 0.75
Quantitative determination of cholesteryl 14-methyl-hexadecanoate by radio-gas chromatography. J Chromatogr (1974) 0.75
[Melanocyte-stimulating hormones]. Cesk Fysiol (1975) 0.75
Chromatographic determination of cholesteryl esters synthesized in vitro. J Chromatogr (1989) 0.75
Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies. Coron Artery Dis (2001) 0.75
[Physical principles of echocardiography]. Vnitr Lek (1978) 0.75
[Pregnancy and labor in women with mitral valve prolapse]. Cas Lek Cesk (1990) 0.75
[The relation of flow velocity in the carotid vessels to age]. Cas Lek Cesk (1989) 0.75
Enhanced utilization of 14-methylhexadecanoic acid for the synthesis of lipids during the growth of Walker 256 carcinoma in rats. Neoplasma (1985) 0.75
[Beta adrenergic receptors in patients with untreated and verapamil-treated hypertrophic cardiomyopathy]. Sb Lek (1988) 0.75
[Prolapse of the mitral valve--anatomic variant or disease?]. Cas Lek Cesk (1988) 0.75
Intermediate complexes in the binding of initiator tRNA to ribosome. Acta Univ Carol Med Monogr (1977) 0.75
[Diameter of the aortic root assessed by means of echocardiography and angiocardiography. Comparative study (author's transl)]. Sb Lek (1978) 0.75
Micropreparative separation of transfer ribonucleic acids by high-performance liquid chromatography. J Chromatogr (1989) 0.75
[Echocardiography in mitral valve valvuloplasty]. Sb Lek (1995) 0.75
[Recommendations for diagnosis and therapy of chronic heart failure. Czech Cardiology Society 2006]. Vnitr Lek (2007) 0.75
Negativity of serological reactions with benzpyrenyl-albumine in the blood of healthy persons and patients with cancer. Neoplasma (1969) 0.75
Alterations of cholesteryl ester metabolism characteristic for cancer. Oncol Rep (2011) 0.75
Pituitary, adrenals and the heart. Cor Vasa (1988) 0.75
Protein synthesis in tumor host. I. Enhanced peptide elongation in transplantable tumors and host liver. Neoplasma (1978) 0.75
[Physical principles of examination methods in cardiology]. Cas Lek Cesk (1988) 0.75
Chicken cell-free protein synthesizing system programmed by endogenous mRNA. Reaction conditions and comparison of normal and tumour systems. Neoplasma (1974) 0.75
Biosynthesis of cholesteryl 14-methylhexadecanoate in the liver of rats bearing transplantable tumors and during chemical carcinogenesis. Neoplasma (1979) 0.75
[Color mapping of blood flow in routine diagnosis in the echocardiography laboratory]. Cas Lek Cesk (1988) 0.75
[ECG Holter monitoring during tocolysis]. Cas Lek Cesk (1987) 0.75
[Incidence and changes in mitral regurgitation in balloon valvotomy of the mitral valve. A color Doppler study]. Cas Lek Cesk (1992) 0.75
[Penile cancer]. Rozhl Chir (1978) 0.75
Changes of E-cadherin and beta-catenin in human and mouse intestinal tumours. Histochem J (2001) 0.75
CTP can replace GTP in reactions catalyzed by eukaryotic peptide elongation factor 1. FEBS Lett (1984) 0.75
Effect of carcinolipin on the adenosine triphosphatase activity of isolated cellular fractions. Nature (1965) 0.75
A critical appraisal of M-mode echocardiography in mitral stenosis. Cor Vasa (1986) 0.75
[Does a hypertensive reaction to dynamic exercise imply an increased risk of developing essential hypertension?]. Cas Lek Cesk (1993) 0.75
Protein synthesis in well-defined subcellular systems from rat liver directed by natural mRNAs. Acta Biol Med Ger (1974) 0.75
[Relation between auscultatory and echocardiographic findings in patients over 60 years of age]. Cas Lek Cesk (1988) 0.75
Guanosine triphosphate - dependent autocatalytic phosphorylation of peptide initiation factor 2 from rat liver. Biochem Biophys Res Commun (1982) 0.75
[On the problem of interaction between carcinogenic hydrocarbons and nucleic acids]. Cas Lek Cesk (1967) 0.75
[Melanocyte-stimulating hormone in various diseases]. Vnitr Lek (1978) 0.75
[Recurrent peripheral arterial embolism from metastatic lung choriocarcinoma]. Cas Lek Cesk (2006) 0.75
Protein synthesis in tumor host. II. Increased activity of peptide elongation factor 1 in experimental rat tumors and in host liver. Neoplasma (1978) 0.75
The effect of N-nitroso carcinogens and triazenes on protein synthesis in cell-free systems. Chem Biol Interact (1974) 0.75
[Is it possible to treat cardiac hypertrophy?]. Cas Lek Cesk (1990) 0.75
[Stress echocardiography in the selection of patients for coronarography]. Vnitr Lek (1993) 0.75
[Color flow mapping--the latest advance in ultrasonic diagnosis in cardiology]. Cas Lek Cesk (1987) 0.75
Formation and 32P-postlabeling of DNA and tRNA adducts derived from peroxidative activation of carcinogenic azo dye N,N-dimethyl-4-aminoazobenzene. Carcinogenesis (1992) 0.75
[Melanocyte-stimulating hormone in women; activity in the urine and blood in pregnant women (author's transl)]. Cas Lek Cesk (1978) 0.75